Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Capital Expenditures (2021 - 2025)

Historic Capital Expenditures for Biofrontera (BFRI) over the last 5 years, with Q3 2025 value amounting to -$1000.0.

  • Biofrontera's Capital Expenditures changed N/A to -$1000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$37000.0, marking a year-over-year decrease of 19024.39%. This contributed to the annual value of $10000.0 for FY2024, which is 10000.0% up from last year.
  • Biofrontera's Capital Expenditures amounted to -$1000.0 in Q3 2025.
  • In the past 5 years, Biofrontera's Capital Expenditures ranged from a high of $57000.0 in Q1 2024 and a low of -$40000.0 during Q4 2024
  • For the 5-year period, Biofrontera's Capital Expenditures averaged around $4571.4, with its median value being $1000.0 (2022).
  • Its Capital Expenditures has fluctuated over the past 5 years, first plummeted by 100000.0% in 2023, then surged by 30714.29% in 2024.
  • Quarter analysis of 5 years shows Biofrontera's Capital Expenditures stood at $9000.0 in 2021, then plummeted by 88.89% to $1000.0 in 2022, then plummeted by 1000.0% to -$9000.0 in 2023, then tumbled by 344.44% to -$40000.0 in 2024, then skyrocketed by 97.5% to -$1000.0 in 2025.
  • Its Capital Expenditures stands at -$1000.0 for Q3 2025, versus $1000.0 for Q2 2025 and $3000.0 for Q1 2025.